¼ÓÈëVIP ÉÏ´«¿¼²©×ÊÁÏ ÄúµÄÁ÷Á¿ Ôö¼ÓÁ÷Á¿ ¿¼²©±¨°à ÿÈÕÇ©µ½
   
Ö÷Ìâ : Ò»¾Å¾Å¾ÅÄ격ʿÉúÈëѧ¿¼ÊÔÊÔÌâ(רҵ»ù´¡: ÃâÒßѧ)
¼¶±ð: ×ܰæÖ÷
ÏÔʾÓû§ÐÅÏ¢ 
Â¥Ö÷  ·¢±íÓÚ: 2007-01-25   

Ò»¾Å¾Å¾ÅÄ격ʿÉúÈëѧ¿¼ÊÔÊÔÌâ(רҵ»ù´¡: ÃâÒßѧ)

Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ MF\n@lX  
3/rvSR!  
£¨ÃâÒßѧרҵºÍרҵ»ù´¡£© h/TPd]  
oh@r0`J]x  
Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© g[M@  
NuO>zAu  
1.Co-stimulators (or co-stimulating molecules) C-Fp)Zs{0  
^Js9E  
2.NK-kB 8&C (0H]1  
e4)g F*  
3.Immunoglobulin superfamily :s'%IGy>:  
~v54$#CB  
4.antigen-presenting cell (APC) NUnP'X=J,  
|(P;2q4>  
5.death domain ^p7(  
?*s!&-KI  
6.CCR and CXCR n#&RY%#`  
?@#}%<yEq  
7.Lectin (or mitogen) -mkync3  
]czy8n$+  
8.Clusters of differentiation, CD) *tO<wp&  
Q]7Q  
9.B7 family 3 #wj-  
>ATW/9r  
10.Cytotoxic T lymphocyte, CTL) IcoL/7k3  
~+np7  
11.IL-15 and IL-15 receptor (IL-15R) jFXU xf  
I>5@s;  
12.MHC restriction `l+SJLyJ%  
Ww(_EW  
13.Affinity-chromatography E nvs[YZe  
Fq9[:  
14.Cyctosprin A, CsA "P{&UwMmh  
;9PM?Iy[  
15.Antibody-dependent cell-mediated cytotoxicity, ADCC) V3oAZ34)  
eI}VHBAz  
¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© cMl%)j-  
|u{QI3 #'  
1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 }SV3PdE  
4cQ5E9  
2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£ (OqJet2{+  
Vi#im`@  
3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹Ô­µÄÌØµã¡£ _o.Z`]  
MQ*#oVqv  
Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£© "AouiZkh  
zcKC5vqb  
ÃâÒßѧרҵ£º 6EU4  
k^pu1g=6I  
1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£ k Ml<  
:*@|"4  
Ïû»¯ÄÚ¿Æ£º @WHd(ka!  
%5*#c*)R  
2.Ö×Áö¿¹Ô­·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ M@g gLW  
zt2-w/[Q  
ѪҺ²¡Ñ§×¨Òµ£º E ZKz-}  
|V\.[F2Fe  
3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔ­Òò£¨Ìõ¼þ£©ÊÇʲô£¿
ÆÀ¼ÛÒ»ÏÂÄãä¯ÀÀ´ËÌû×ӵĸÐÊÜ

¾«²Ê

¸Ð¶¯

¸ãЦ

¿ªÐÄ

·ßÅ­

ÎÞÁÄ

¹àË®

  
ÃèÊö
¿ìËٻظ´

ÑéÖ¤ÎÊÌâ:
2+6=? ÕýÈ·´ð°¸:8
°´"Ctrl+Enter"Ö±½ÓÌá½»